These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 24363358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
    Green JJ, Berger JS, Kramer CM, Salerno M.
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
    [Abstract] [Full Text] [Related]

  • 3. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
    Ota S, Orii M, Nishiguchi T, Yokoyama M, Matsushita R, Takemoto K, Tanimoto T, Hirata K, Hozumi T, Akasaka T.
    J Cardiovasc Magn Reson; 2021 Mar 25; 23(1):32. PubMed ID: 33761955
    [Abstract] [Full Text] [Related]

  • 4. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P, Kivistö S, Holmström M, Hänninen H.
    BMC Cardiovasc Disord; 2014 Aug 27; 14():110. PubMed ID: 25160650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I, Bezerra H, Carrick D, Tzemos N.
    JACC Cardiovasc Imaging; 2015 May 27; 8(5):540-549. PubMed ID: 25890580
    [Abstract] [Full Text] [Related]

  • 7. A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study.
    Zhou D, Zhu L, Wu W, Zhuang B, He J, Xu J, Yang W, Wang Y, Li S, Sun X, Sharma P, Liu G, Sirajuddin A, Arai A, Zhao S, Lu M.
    Eur Radiol; 2024 Jun 27; 34(6):4053-4064. PubMed ID: 37950081
    [Abstract] [Full Text] [Related]

  • 8. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
    Anagnostopoulos I, Kousta M, Kossyvakis C, Lakka E, Paraskevaidis NT, Schizas N, Alexopoulos N, Deftereos S, Giannopoulos G.
    J Interv Card Electrophysiol; 2022 Apr 27; 63(3):523-530. PubMed ID: 34218421
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D, Ye M, Zhang L, Jiang B.
    Heart Lung; 2018 Apr 27; 47(2):122-126. PubMed ID: 29174363
    [Abstract] [Full Text] [Related]

  • 10. The extent of late gadolinium enhancement predicts mortality, sudden death and major adverse cardiovascular events in patients with nonischaemic cardiomyopathy: a systematic review and meta-analysis.
    Golukhova EZ, Bulaeva NI, Alexandrova SA, Mrikaev DV, Gromova OI, Ruzina EV, Berdibekov BS.
    Clin Radiol; 2023 Apr 27; 78(4):e342-e349. PubMed ID: 36707397
    [Abstract] [Full Text] [Related]

  • 11. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
    Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O'Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK.
    JAMA; 2013 Mar 06; 309(9):896-908. PubMed ID: 23462786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H.
    JACC Cardiovasc Imaging; 2013 Apr 06; 6(4):501-11. PubMed ID: 23498675
    [Abstract] [Full Text] [Related]

  • 14. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M, De Lazzari M, Zorzi A, Migliore F, Zilio F, Calore C, Vettor G, Tona F, Tarantini G, Cacciavillani L, Corbetti F, Giorgi B, Miotto D, Thiene G, Basso C, Iliceto S, Corrado D.
    Heart Rhythm; 2014 May 06; 11(5):856-63. PubMed ID: 24440822
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis.
    Wang J, Yang F, Wan K, Mui D, Han Y, Chen Y.
    ESC Heart Fail; 2020 Oct 06; 7(5):2184-2192. PubMed ID: 32603034
    [Abstract] [Full Text] [Related]

  • 18. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
    Lyons KS, Dixon LJ, Johnston N, Noad R, Hamilton A, McKeag N, Horan P.
    Cardiol J; 2014 Oct 06; 21(1):29-32. PubMed ID: 23990187
    [Abstract] [Full Text] [Related]

  • 19. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG, Lee HJ, Park J, Uhm JS, Pak HN, Lee MH, Kim YJ, Joung B.
    Int J Cardiol; 2016 Nov 01; 222():9-15. PubMed ID: 27458824
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.